FDA Inspection 1151636 — Rocky Mountain Center for Reproductive Medicine
The FDA completed an inspection of Rocky Mountain Center for Reproductive Medicine on July 21, 2021 in Fort Collins, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 21, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fort Collins, CO (United States)